Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Depreciation and Depletion (2016 - 2026)

Akebia Therapeutics has reported Depreciation and Depletion over the past 9 years, most recently at $321000.0 for Q4 2025.

  • Quarterly Depreciation and Depletion fell 4.18% to $321000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 13.2% year-over-year, with the annual reading at $1.3 million for FY2025, 13.2% down from the prior year.
  • Depreciation and Depletion was $321000.0 for Q4 2025 at Akebia Therapeutics, up from $318000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $408000.0 in Q4 2022 and troughed at $314000.0 in Q1 2025.
  • The 4-year median for Depreciation and Depletion is $364000.0 (2024), against an average of $363384.6.
  • Year-over-year, Depreciation and Depletion rose 0.76% in 2024 and then fell 21.0% in 2025.
  • A 4-year view of Depreciation and Depletion shows it stood at $408000.0 in 2022, then dropped by 3.43% to $394000.0 in 2023, then fell by 14.97% to $335000.0 in 2024, then dropped by 4.18% to $321000.0 in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Depreciation and Depletion are $321000.0 (Q4 2025), $318000.0 (Q3 2025), and $316000.0 (Q2 2025).